Page 72 - 86_01

ANALES
33.
20. Maron BA, Zhang YY, White K, Chan SY, Handy DE, Mahoney CE, Loscalzo
J, Leopold JA. Aldosterone inactivates the endothelin-B receptor via a
cysteinyl thiol redox switch to decrease pulmonary endothelial nitric oxide
levels and modulate pulmonary arterial hypertension. Circulation. 2012;
126(8):963-74.
21. Schäfer N, Lohmann C, Winnik S, van Tits LJ, Miranda MX, Vergopoulos
A, Ruschitzka F, Nussberger J, Berger S, Lüscher TF, Verrey F, Matter CM.
Endothelial mineralocorticoid receptor activation mediates endothelial
dysfunction in diet-induced obesity. Eur Heart J. 2013; 34(45):3515-24.
22. Virdis A, Neves MF, Amiri F, Viel E, Touyz RM, Schiffrin EL. Spironolactone
improves angiotensin-induced vascular changes and oxidative stress.
Hypertension. 2002; 40(4):504-10.
23. Iglarz M, Touyz RM, Viel EC, Amiri F, Schiffrin EL. Involvement of oxidative
stress in the profibrotic action of aldosterone. Interaction wtih the renin-
angiotension system. Am J Hypertens. 2004; 17(7):597-603.
24. Leibovitz E, Ebrahimian T, Paradis P, Schiffrin EL. Aldosterone induces ar-
terial stiffness in absence of oxidative stress and endothelial dysfunction.
J Hypertens. 2009; 27(11):2192-200.
25. Kasal DA, Barhoumi T, Li MW, Yamamoto N, Zdanovich E, Rehman A,
Neves MF, Laurant P, Paradis P, Schiffrin EL. T regulatory lymphocytes pre-
vent aldosterone-induced vascular injury. Hypertension. 2012; 59(2):324-
30.
26. Dinh QN, Young MJ, Evans MA, Drummond GR, Sobey CG, Chrissobolis S.
Aldosterone-induced oxidative stress and inflammation in the brain are
mediated by the endothelial cell mineralocorticoid receptor. Brain Res.
2016; 1637:146-153.
27. Briet M, Barhoumi T, Mian MOR, Coelho SC, Ouerd S, Rautureau Y, Coff-
man TM, Paradis P, Schiffrin EL. Aldosterone-Induced Vascular Remodeling
and Endothelial Dysfunction Require Functional Angiotensin Type 1a Re-
ceptors. Hypertension. 2016; 67(5):897-905.
28. Jia G, Habibi J, Aroor AR, Martinez-Lemus LA, DeMarco VG, Ramirez-
Pérez FI, Sun Z, Hayden MR, Meininger GA, Mueller KB, Jaffe IZ, Sowers
JR. Endothelial Mineralocorticoid Receptor Mediates Diet-Induced Aortic
Stiffness in Females. Circ Res. 2016; 118(6):935-943.
29. Jia G, Habibi J, Aroor AR, Hill MA, Yang Y, Whaley-Connell A, Jaisser F,
Sowers JR. Epithelial Sodium Channel in Aldosterone-Induced Endothelium
Stiffness and Aortic Dysfunction. Hypertension. 2018; 72(3):731-738.
30. Beswick RA, Dorrance AM, Leite R, Webb RC. NADH/NADPH oxidase and
enhanced superoxide production in the mineralocorticoid hypertensive rat.
Hypertension. 2001; 38(5):1107-11.
31. Lassègue B, San Martín A, Griendling KK. Biochemistry, physiology, and
pathophysiology of NADPH oxidases in the cardiovascular system. Circ Res.
2012; 110(10):1364-90.
32. Nguyen Dinh Cat A, Montezano AC, Burger D, Touyz RM. Angiotensin II,
NADPH oxidase, and redox signaling in the vasculature. Antioxid Redox
Signal. 2013; 19(10):1110-20.
70 ble nueva diana para combatir el daño vascular.
RANF
www.analesranf.com
33. Touyz RM, Briones AM. Reactive oxygen species and vascular biology: im-
plications in human hypertension. Hypertens Res. 2011; 34(1):5-14.
34. Park YM, Lim BH, Touyz RM, Park JB. Expression of NAD(P)H oxidase su-
bunits and their contribution to cardiovascular damage in aldosterone/salt-
induced hypertensive rat. J Korean Med Sci. 2008; 23(6):1039-45.
35. Montezano AC, Callera GE, Yogi A, He Y, Tostes RC, He G, Schiffrin EL,
Touyz RM. Aldosterone and angiotensin II synergistically stimulate migra-
tion in vascular smooth muscle cells through c-Src-regulated redox-sensitive
RhoA pathways. Arterioscler Thromb Vasc Biol. 2008; 28(8):1511-8.
36. Cannavo A, Liccardo D, Eguchi A, Elliott KJ, Traynham CJ, Ibetti J, Eguchi
S, Leosco D, Ferrara N, Rengo G, Koch WJ. Myocardial pathology induced
by aldosterone is dependent on non-canonical activities of G protein-cou-
pled receptor kinases. Nat Commun. 2017; 7:10877.
37. De Giusti VC, Orlowski A, Ciancio MC, Espejo MS, Gonano LA, Caldiz CI,
Vila Petroff MG, Villa-Abrille MC, Aiello EA. Aldosterone stimulates the car-
diac sodium/bicarbonate cotransporter via activation of the g protein-cou-
pled receptor gpr30. J Mol Cell Cardiol. 2015; 89(Pt B):260-7.
38. Ashton AW, Le TY, Gómez-Sánchez CE, Morel-Kopp MC, McWhinney B,
Hudson A, Mihailidou AS. Role of Nongenomic Signaling Pathways Acti-
vated by Aldosterone During Cardiac Reperfusion Injury. Mol Endocrinol.
2015; 29(8):1144-55.
39. Sanz-Rosa D1, Oubiña MP, Cediel E, De las Heras N, Aragoncillo P, Bal-
fagón G, Cachofeiro V, Lahera V. Eplerenone reduces oxidative stress and
enhances eNOS in SHR: vascular functional and structural consequences.
Antioxid Redox Signal. 2005; 7(9-10):1294-301.
40. Mulder P, Mellin V, Favre J, Vercauteren M, Remy-Jouet I, Monteil C, Ri-
chard V, Renet S, Henry JP, Jeng AY, Webb RL, Thuillez C. Aldosterone
synthase inhibition improves cardiovascular function and structure in rats
with heart failure: a comparison with spironolactone. Eur Heart J. 2008;
29(17):2171-9.
41. Silva MA, Bruder-Nascimento T, Cau SB, Lopes RA, Mestriner FL, Fais RS,
Touyz RM, Tostes RC. Spironolactone treatment attenuates vascular dysfunc-
tion in type 2 diabetic mice by decreasing oxidative stress and restoring
NO/GC signaling. Front Physiol. 2015; 6:269.
42. Silva MA, Cau SB, Lopes RA, Manzato CP, Neves KB, Bruder-Nascimento
T, Mestriner FL, Montezano AC, Nguyen Dinh Cat A, Touyz RM, Tostes RC.
Mineralocorticoid receptor blockade prevents vascular remodelling in a ro-
dent model of type 2 diabetes mellitus. Clin Sci (Lond). 2015; 129(7):533-
45.
43. Nguyen Dinh Cat A, Griol-Charhbili V, Loufrani L, Labat C, Benjamin L,
Farman N, Lacolley P, Henrion D, Jaisser F. The endothelial mineralocor-
ticoid receptor regulates vasoconstrictor tone and blood pressure. FASEB
J. 2010; 24(7):2454-63.
44. Davel AP, Anwar IJ, Jaffe IZ. The endothelial mineralocorticoid receptor:
mediator of the switch from vascular health to disease. Curr Opin Nephrol
Hypertens. 2017; 26(2):97-104.
45. Davel AP, Lu Q, Moss ME, Rao S, Anwar IJ, DuPont JJ, Jaffe IZ. Sex-Specific
Receptor mineralocorticoide extrarrenal. Una posi-
Ana M. Briones y Raquel Rodrigues-Díez
An Real Acad Farm Vol. 86. Nº 1 (2020) · pp. 61 -73